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ABSTRACT: Postmortem redistribution (PMR) refers to the site- and time- related blood drug concentration 
variations after death. We compared central blood (cardiac and subclavian) with peripheral blood (femoral and 
popliteal) concentrations of diazepam, methadone and morphine. To our knowledge, popliteal blood has never 
been compared with other sites. Intracardiac blood (ICB), subclavian blood (SB), femoral blood (FB) and 
popliteal blood (PB) were sampled in 30 cases. To assess PMR, mean concentrations and ratios were compared. 
Influence of postmortem interval on mean ratios was also assessed. Results show that popliteal mean 
concentrations were lower than other sites for all three drugs, even than femoral blood, mean ratios suggested 
that popliteal site was less subject to PMR and estimated postmortem interval did not influence ratios except for 
diazepam and methadone FB/PB. In conclusion, our study is the first to explore popliteal site and suggests that 
popliteal blood is less prone to postmortem redistribution.  
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The postmortem redistribution (PMR) of a substance is a phenomenon that describes the site- and time-
dependent change in the concentration of a compound in the blood after death. It is amply described elsewher  
(2,3,4,5,10,13,17). It is impossible to predict the extent to which a substance will redistribute after death, but pH, 
large volume of distribution, protein binding and how lipophilic the compound is all seem to play a role (2,3,7). 
There are other factors probably involved, such as bacterial bre kdown and other putrefactive processes (2,3,21). 
Sampling from central sites (subclavian vessels and heart) tends to be more affected by PMR than peripheral 
sites (iliac and femoral vessels). The extent to which a drugis prone to postmortem redistribution is usually 
described by the ratio of the Central (C) to Peripheral (P) concentration of a drug, or C/P ratio (2,3,10,13,16). 
Higher ratios imply greater postmortem redistribution. Some authors suggest that the [C]/[P] ratio is not always  
reliable indicator of postmortem redistribution for a particular substance (7,26,27). Femoral sampling, ideally 
done after dissection and clamping of the vessel, is currently considered the blood sampling site of choice since 
it is less subject to the processes that cause postmortem redistribution (2,3,4). The blindstick method of drawing 
femoral blood is considered equivalent (24). There are papers that suggest that subclavian sampling should not 
be considered a strictly central site, but rather an intermediate one (15,16). Some authors used dissection and 
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knowledge, the popliteal vein has never been described as a sampling site. Because of its distance from the trunk 
and a usually sterile site in life, it theoretically is a more favorable site for taking a peripheral sample. 
Other than the sampling site, the postmortem interval appears to be important, especially shortly after death, 
which is when most postmortem redistribution is thought to occur. Although passive diffusion from reservoir 
organs theoretically occurs within the first few hours after death (2,3), celular autolysis and the putrefactive 
action of bacteria could also result in later changes as uggested by some studies (8,25). 
In this study, we sampled a number of drugs from popliteal blood and compared the results obtained there with 
concentrations obtained from routine sampling sites. We chose drugs more commonly abused in th  jurisdiction 
of the Medico-Legal Institute of the University of Liège, Belgium. These were diazepam, methadone and 
morphine. They are also compounds subject to postmortem redistribution (1,5,6,7,8,9,12,14,18,19,21). 
Methods 
We included 30 cases that came to our medico-legal office in Liège between November 2012 and November 
2013. A urine drug screen was done to assess the presence of the drugs of interest (Drug-Screen®, nal von 
minden GmbH).  
Intracardiac blood (ICB), subclavian blood (SB), femoral blood (FB) and popliteal blood (PB) were drawn. 
Cardiac blood was always sampled in the right atrium, accessed via a sm ll chest dissection. For the subclavian 
and femoral vein samples, transcutaneous sampling (blind stick) was done on the left, and issection with 
proximal clamping was done on the right. Because the popliteal vessels are deep in the posterior aspect of the 
knee, dissection for access is necessary, and the popliteal vein clamped as cephalad as possible to prevent any 
theoretical femoral blood reflux during sampling. After popliteal vein dissection and clamping, compression of 
the leg was sometimes required to obtain an adequate amount of blood for testing (i.e. 2-5 ml from each side).  
Diazepam, methadone and morphine were assayed. Blood samples were put into NaF tubes and frozen at -20 °C 
prior to analysis which was performed quickly i.e. within first weeks (4 to 6 weeks) after sampling. 
The postmortem interval was estimated using routine observations from the scene of death and assessment of 
postmortem changes (ambient and rectal temperatures, lividity, rigidity, state of decomposition, skin slippage, 
eye changes, bloating, discoloration, etc). This was done for each case.  
 
Quantitative Analysis 
The quantification of morphine and methadone was performed on an ultra-high pressure liquid chromatograph 
Acquity® coupled to a tandem mass spectrometer Quattro Premier® (Waters, Zellik, Belgium). After solid phase 
extraction of the sample on Oasis MCX® cartridges, the separation was performed on an Acquity HSS T3 
column. The mobile phase consisted in a gradient of ammonium formate (pH 3) and acidified methanol (22). 
Diazepam was analyzed in blood using a high performance liquid chromatography with photodiode array 
detection (Alliance®, Waters) based on a method described by Y. Gaillard et al. (23). After a liquid-liquid 
extraction using a mixture of diethyl ether, dichlormethane, hexane and n- myl alcohol, the sample was injected 
on a Symmetry C8 column with phosphate buffer (pH 3.8) and acetonitrile delvered according to a gradient 
mode as mobile phase. Mean coefficient of variation (CV) was respectively 4.00 % for diazepam, 5.08 % for 
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Statistical Analysis 
Statistical analyses were performed by using SAS software (version 9.3 for windows) and R software. Normality 
of the distributions was checked by using a Shapiro-Wilk test. A logarithmic transformation of concentrations 
was also used to normalize the distributions.  
For each substance, mean concentrations at each site were calculated and the 4 sampling sites were compared 
with a non-parametric Friedman test. For the comparison of concentrations in the different sampling sites and for 
the comparison of mean ratios, a Bonferroni’s correction (0.05/6 = 0.0083) was used to consider statistically 
significant results (p<0.0083).  
For each substance, drug concentrations differences between sites were calculated as follows: ICB – SB, ICB – 
FB, ICB – PB, SB – FB, SB – PB, and FB – PB. A non-parametric Wilcoxon signed-rank test was used to assess 
a significant concentration difference. 
For each substance, the following ratios were calculated: ICB / SB, ICB / FB, ICB / PB, SB / FB, S / PB and 
FB / PB. A non-parametric Wilcoxon signed-rank test was also utilized to assess a significant ratio, i.e. a ratio 
different to 1. 
Quantitative variables were summarized by the mean, standard deviation (SD), median, minimum and 
maximum. Qualitative variables were summarized by means of number (N) and percentage (%). 
To assess the influence of post-mortem interval, non-parametric Spearman correlation coefficients were 
calculated to assess the correlation between ratios and estimated postmortem interval. A negative coefficient 
showed a decreasing relation between the two parameters (when one increased, the other decreased) while a 
positive coefficient showed an increasing relation (when one increased, the other increased too). For assessing 
the influence of post-mortem interval, results were considered as statistically significant at 5% level (p< 0.05). 
 
Results 
Table 1 shows age, sex and average estimated postmortem interval as determined by the protocol in use by our 
office. 
Table 2 shows targeted substances and their respective frequencies.   
Table 3 shows, for each case, concentrations for each substance and by site, ratios for each substance, suspected 
mode of delivery for each substance as well as cause and manner of death according to external examination, 
toxicological findings and elements from death scene. 
Concerning delivery mode, oral ingestion was always used for diazepam and methadone, whereas morphine was 
orally ingested in one case (case #1) and smoked or injected as heroin in respectively 14 and 2 cases (case #9 and 
20).  
Concerning concentrations and ratios, some interesting findings concern intracardiac blood with ICB/FB and 
even ICB/PB ratios found very low (ie less than 0.80) in some cases.  
An ICB/FB ratio less than 1 was a common finding for diazepam in 10 of 14 cases, probably depending on 
benzodiazepines higher instability in postmortem blood. Methadone and morphine showed l ss frequently such 
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Concerning methadone, cases #2, 10, 17, 19, 22, 29 and 30 showed ICB/FB ratios less than 0.80. According to 
the respective context, it suggested either rapid death with incomplete distribution and/or recent use of 
methadone with probably shorter accumulation of the drug in the myocardium and other reservoir organs. 
However, in cases #2 and 17, ICB/PB ratios were greater than 1. SB/FB ratios were less than 1 in 4 cases (#5, 
11, 17 and 22) but never less than 0.86, whereas SB/PB ratios were always greater than 1. Our findings may 
indicate than ICB is probably more concerned with incomplete distribution and/or recent methadone use than 
SB. 
Morphine was associated with ICB/FB ratio less than 1 in only one case (case #4) where cause of death was 
found to be methadone intoxication, suggesting that the victim could have smoked heroin a short time before 
unconsciousness and death, accounting for an incomplete distribution. I  the two cases where heroin was 
injected and death attributed to it, there was no negative ratio. Furthermore, there was only one SB/FB ratio less 
than 1 (case # 13) and, exc pt in case # 1 (0.93), all SB/PB ratios were greater than 1. This is probably because 
of delivery mode of morphine (smoking and injection in 16 of 17 cases) allowing distribution to occur 
significantly quicker than for methadone (always orally ingested).  
Figure 1 (a,b,c) shows drugs blood concentrations distribution with mean concentration and standard deviation 
(y-axis) for each sampling site (x-axis). For methadone, ICB is shown on a separate graph from SB, FB and PB, 
because of one significant outlier. 
ICB, SB, FB and PB mean concentrations tend to decline the further the sampling site is from the heart, except 
for diazepam, which shows a slightly higher femoral blood c ncentration. Popliteal mean concentrations are 
lower than other three sites for all drugs.  
Figure 2 shows mean drug concentrations differences between sites. Cardiac and subclavian sites show no 
significant mean concentration differences for the three compounds. Cardiac n  femoral sites show statistically 
significant mean concentrations differences for morphine (p=0.0026); cardiac blood concentrations are 
consistently higher than femoral blood. For methadone (p=0.0051) and morphine (p=0.0001), cardiac and 
popliteal sites show significant mean concentration differences; so do subclavian and femoral sites (methadone 
p<0.0001, morphine p=0.0004). Subclavian and popliteal sites show significant me concentrations differences 
for the three drugs (diazepam p=0.0006, methadone p<0.0001, morphine p<0.0001). This is also true for the 
difference between femoral and popliteal sampling sites; for all three cases, the popliteal sample had the lowest 
concentrations (diazepam p=0.0005, methadone p<0.0001, morphine p=0.0005). 
All concentrations are expressed in microgram per liter of blood (µg/L). 
To assess the occurrence of postmortem redistribution, for each substance, the following average ratios of 
concentrations were obtained: ICB/SB, ICB/FB, ICB/PB, SB/FB, SB/PB and FB/PB as shown in Table 4. 
ICB/SB mean ratios are not statistically significant, i.e. different from 1, for any substances. ICB/FB mean ratios 
are not statistically significant, i.e. different from 1, for any substances. ICB/PB mean ratios are statistically 
greater than 1, for methadone and morphine but are not statistically significant, i.e. different from 1, for 
diazepam. SB/FB means ratios are statistically greater than 1, for methadone and morphine but show no 
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and morphine but are not statistically significant, i.e. different from 1, for diazepam. FB/PB mean ratios are 
statistically greater than 1 for all three targeted-substances.  
Figure 3 illustrates the mean concentrations ratios for the 3 compounds. ICB/FB and SB/FB ratios are 
consistently less than the ICB/PB and SB/PB ratios. For methadone and morphine, FB/PB ratios are consistently 
lower than the more usual central (cardiac/subclavian) / peripheral (femoral/popliteal) ratios. For diazepam, the 
FB/PB diazepam ratio is greater than the central (cardiac/subclavian) / peripheral (femoral/popliteal) ratios. 
 
To assess the influence of postmortem interval, for each substance, the correlations between ratios of 
concentrations obtained and the estimated postmortem interval were calculated as shown in Table 5. There is 
only a significant correlation between postmortem interval and F/P ratio for diazepam (r = 0.57, p = 0.032) and 




For morphine and methadone, our results were consistent with those described in the literature, i.e., these 
compounds are subject to PMR (4,5,6,11,12,14,19). For diazepam, ICB/FB and SB/FB ratios were constantly 
lower than or equal to 1, which is not consistent with other studies (5,9,14,15). However, one study describing 
nordiazepam and bromazepam showed the same trend (1).  
According to some authors, diazepam is stable in blood and tissues (28,35), even with putrefaction (29), unlike 
other benzodiazepines (21,29,30) although this can depend on specimen preservation (30,39), temperature 
(31,31,32,39), and other factors (32,39). In our study, a C/P ratio less than 1 was ob erved for diazepam when 
comparing femoral to central blood concentrations, suggesting that diazepam is not subject to redistribution. 
Because of blood was collectd in NaF tube then frozen within one hour after sampling and quickly analyzed 
(within weeks), the diazepam mean C/P ratio less than 1 may also suggest central degradation before sampling 
especially as the FB/PB ratio was significantly greater than 1. Then, our results may indicate that degradation of 
diazepam actually occurred and was stronger in more central sites and less important in peripheral 
compartments, due to the much slower bacterial proliferation in extremities. However, our results may also 
reflect more complex changes in diazepam blood concentrations as for other benzodiazepines, and further 
sampling efforts are needed. 
With regard to the stability of morphine and glucuronides, some authors did not see significant changes in 
morphine and glucuronides concentrations in patient samples and stored blood even when compared with 
admission and postmortem blood, in some cases for days after the sample was drawn (12,20,35,36,37). Other 
studies showed that increased storage time, temperature and degree of putrefaction resulted in greater free 
morphine generation (33) whereas morphine and its glucuronides were stable in sampled post-mortem blood 
only when stored at -20°C (34,38). In this study, in order to avoid pre-analysis drug degradation, blood sampled 
was systematically collected into a sodium fluoride/potassium oxalate vial and frozen at -20 °C prior to analysis 
which was performed quickly i.e. within first weeks (4 to 6 weeks) after sampling. The mean post-mortem 
interval was 33.3 ± 17.8 hours, which means that significant bacterial proliferation in the extremities had not 
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Popliteal blood mean concentrations are significantly lower than those observed in f moral blood. In most 
situations, a femoral or popliteal blood sample better approximates an antemortem concentration of a drug, at 
least for the 3 drugs studied here. Because the FB/PB ratios are all significantly greater than 1, the popliteal vein 
is likely a better site to approximate the antemortem concentration of a drug. 
Our results also show that there no statistically significant difference between cardiac nd subclavian blood 
concentrations for diazepam, methadone and morphine; for practical purposes, ther  is no difference when 
sampling from either site. Intracardiac morphine concentrations tended to be higher than those in subclavian 
samples, but in practice this probably does not make a differenc , specially if the blood is obtained from a blind 
stick. Diazepam mean ratios tended to rise in more peripheral sampling sites, which means the drug 
concentration rises in the more distal samples. This may be due to decreased degradation of diazepam in 
compartments distal to the trunk. 
Postmortem interval did not significantly influence results except for diazepam and methadone FB/PB ratios, 
where longer postmortem intervals correlated with increased ratios. Our results are consistent with some authors 
suggesting that PMR occurs within the first few hours after death because of early passive diffusion from 
reservoir organs like lungs (2,3). Our results also show that, for diazepam and methadone, redistribution may 
still occur at femoral site while not in popliteal blood, strengthening the hypothesis that popliteal blood is less 
prone to PMR. Some authors have demonstrated significant changes in femoral blood concentrations with time 
for some drugs whereas other dugs, yet with the same pharmacological properties, did not show the same trend. 
Saar et al. (25) demonstrated significant changes with time for antipsychotic drugs like clozapine, olanzapine and 
zuclopenthixol but haloperidol did not show the same trend, even those drugs are basic and lipophilic with a 
large Vd  and one could expect that they are lik ly to undergo PMR. Besides, Geroustamoulos et al. (8) found 
that methadone, mirtazapine and sertraline femoral blood concentrations showed statistically significant 
increases irrespective of the delay in the postmortem interval, whereas olanzapine and diazepam concentrations 
were found to be stable with postmortem interval. Those results suggest that the phenomenon is actually more 
complex and may involve other mechanisms as well as large interindividual variations. Furthermore, because the 
postmortem interval is itself more often than not an estimate, only those cases where an antemortem blood 
sample can be compared to a postmortem sample will resolve the question, as it can happen in cases that survive 
long enough to undergo resuscitation in a hospital setting. In any case, one should be aware of the potential 
concentration changes with time and ideally encourage sampling as soon as possible after death.  
 
In conclusion, our study is the first to describe popliteal blood concentrations of diazepam, methadone and 
morphine and shows that sampling from this site results in drug concentrations lower than those in cardiac, 
subclavian and even femoral sampling. This suggests that popliteal blood is less prone to postmortem 
redistribution. The reasons for this are unclear, but distance from the trunk and isolation from many of the 
contributing factors to postmortem redistribution must certainly play a role. The concentrations of these three 
drugs obtained from femoral blood and popliteal blood are also comparable, indicating that femoral blood is still 
a good sample for obtaining peripheral blood. However, because popliteal blood concentrations are lower than 
those obtained from femoral blood, it is likely that drug concentrations obtained from this site even more closely 
































1. Pos Pok PR, Haddouche D, Mauras M, Kuhlmann E, Burle J, Salmon T et al. Cardiac and peripheral blood 




Pélissier-Alicot AL , Gaulier JM, Champsaur P, Marquet P. Mechanisms underlying postmortem redistribution 
of drugs: a review. J Anal Toxicol 2003
3. 
;27(8):533–44. 
Yarema MC, Becker CE. Key concepts in postmortem drug redistribution. Clin Toxicol 2005;43(4):235–41. 
4. Cook DS, Braithwaite RA, Hale KA. Estimating antemortem drug concentrations from postmortem blood 
samples: the influence of postmortem redistribution. J Clin Pathol 2000;53(4):282–5. 
5. Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol 2008;66(4):430–43.  
6. Crandall CS, Kerrigan S, Blau RL, Lavalley J, Zumwalt R, McKinney PE. The influence of site of collection 
on postmortem morphine concentrations in heroin overdose victims. J Forensic Sci 2006;51(2):413–20. 
7. Rodda KE, Drummer OH. The redistribution of selected psychiatric drugs in post-mortem cases. Forensic Sci 
Int 2006;164(2-3):235–9.  
8. Gerostamoulos D, Beyer J, Staikos V, Tayler P, Woodford N, Drummer OH. The effect of the postmortem 
interval on the redistribution of drugs: a comparison of mortuary admission and autopsy blood specimens. 
Forensic Sci Med Pathol 2012;8(4):373–9.  
9. Han E, Kim E, Hong H, Jeong S, Kim J, In S, Chung H, Lee S. Evaluation of postmortem redistribution 
phenomena for commonly encountered drugs. Forensic Sci Int 2012;219(1-3):265–71.  
10. Kennedy MC. Post-mortem drug concentrations. Intern Med J 2010;40(3):183–7.  
11. Wyman J, Bultman S. Postmortem distribution of heroin metabolites in femoral blood, liver, cerebrospinal 
fluid, and vitreous humor. J Anal Toxicol 2004;28(4):260–3. 
12. Skopp G, Lutz R, Ganssmann B, Mattern R, Aderjan R. Postmortem distribution pattern of morphine and 

















This article is protected by copyright. All rights reserved 
13. Drummer OH. Postmortem toxicological redistribution. In: Rutty GN, editor. Essentials of autopsy practice. 
London, U.K.: Springer-Verlag, 2008;1–21. 
14. Hepler BR, Isenschmid DS, Schmidt CJ. Postmortem redistribution: practical considerations in death 
investigation. Proceedings of the 2004 Annual Meeting American Academy of Forensic Sciences; 2004 Feb 16-
21; Dallas, TX. Colorado Springs, CO: American Academy of Forensic Sciences, 2004. 
15. Molina DK, Hargrove VM. Should postmortem subclavian blood be considere  a peripheral or central 
sample? Am J Forensic Med Pathol 2013;34(2):155–8.  
16. Prouty RW, Anderson WH. The forensic science implications of site and temporal influences on postmortem 
blood-drug concentrations. J Forensic Sci 1990;35(2):243–70. 
17. Sastre C, Baillif -Couniou V, Musarella F, Bartoli C, Mancini J, Piercecchi-Marti et al. Can subclavian blood 
be equated with a peripheral blood sample? A series of 50 cases.Int J Legal Med 2013;127(2):379–84. 
18. Hargrove VM, Molina DK. Peripheral postmortem redistribution of morphine. Am J Forensic Med Pathol 
2014;35(2):106–8. 
19. Logan BK, Smirnow D. Postmortem distribution and redistribution of morphine i man. J Forensic Sci 
1996;41(2):221–9. 
20. Hadidi KA, Oliver JS. Stability of morphine and buprenorphine in whole blood. Int J Legal Med 
1998;111(3):165–7.  
21. Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int 2004;142(2-3):101–13. 
22. Dubois N, Debrus B, Hubert Ph, Charlier C. Validated quantitative simultaneous determination of cocaine, 
opiates and amphetamines in serum by U-HPLC coupled to tandem mass spectrometry. Acta Clin Belg 
2010;65(1):75–84. 
23. Gaillard Y, Pépin G. Use of high-performance liquid chromatography with photodiode array UV detection 
for the creation of a 600-compound library. Application to forensic toxicology. J Chromatogr A 1997;763:149–
63. 
24. Hargrove VM, McCutcheon JR. Comparison of drug concentrations taken from clamped and unclamped 
femoral vessels. J Anal Toxicol 2008;32(8):621–5. 
25. Saar E, Beyer J, Gerostamoulos D, Drummer OH. The time-dependant post-mortem redistribution of 
antipsychotic drugs. Forensic Sci Int 2012;222(1-3):223–7. 
26. McIntyre IM. Liver and peripheral blood concentration ratio (L/P) as a marker of postmorte  drug 
redistribution: a literature review. Forensic Sci Med Pathol 2014
27. 
;10(1):91–6.  
McIntyre IM, Meyer Escott C. Postmortem drug redistribution. J Forensic Res 2012;3:6. 
28. Levine B, Blanke RV, Valentour JC. Postmortem stability of benzodiazepines in blood and tissues. J 
Forensic Sci 1983;28(1):102–15.  
29. Stevens HM. The stability of some drugs and poisons in putrefying human liver tissues. J Forensic Sci Soc 
1984;24(6):577–89.  
30. Robertson MD, Drummer OH. Postmortem drug metabolism by acteria. J Forensic Sci 1995;40(3):382–6.  
31. El Mahjoub A, Staub C. Stability of benzodiazepines in whole blood samples stored at varying temperatures. 
J Pharm Biomed Anal 2000;23(6):1057–63.  
32. Skopp G, Pötsch L, König I, Mattern R. A preliminary study on the stability of benzodiazepines in blood and 

















This article is protected by copyright. All rights reserved 
33. Carroll FT, Marraccini JV, Lewis S, Wright W. Morphine-3-D glucuronide stability in postmortem 
specimens exposed to bacterial enzymatic hydrolysis. Am J Froensic Med Pathol 2000;21(4):323–9.  
34. Skopp G, Pötsch L, Klingmann A, Mattern R. Stability of morphine, morphine-3-glucuronide, and morphine-
6-glucuronide in fresh blood and plasma and postmortem blood samples. J Anal Toxicol 2001;25(1):2–7.  
35. Karinen R, Andresen W, Smith-Kielland A, Morland J. Long-term storage of authentic postmortem forensic 
blood samples at -20°C: measured concentrations of benzodiazepines, central stimulants, opioids and certain 
medicinal drugs before and after storage for 16-18 years. J Anal Toxicol 2014;38:686–95. 
36. Gerostamoulos J, Drummer OH. Postmortem redistribution of morphine and its metabolites. J Forensic Sci  
2000;45(4):843-5. 
37. Hargrove VM, Molina DK. Peripheral postmortem redistribution of morphine. Am J Forensic Med Pathol 
2014;35(2):106–8.  
38. Papoutsis I, Nikolaou P, Pistos C, Dona A, Stefanidou M, Spiliopoulou C et al. Stability of morphine, 
codeine, and 6-acetylmorphine in blood at different sampling and storage conditions. J Forensic Sci 2014 
Mar;59(2):550–4. 
39. Atanasov V, Stoykova S., Runiov A., Dimitrova T., Aleksandrova D., Tsakovski S. et al. Stability of 






Additional information and reprint requests: 
Eric Lemaire, M.D. 
Department of Forensic Medicine  


































TABLE 1—Sex, age and estimated postmortem interval.  
 N Mean +/- SD Min-Max 
Sex    
Male 23   
Female 7   
Age (y) 30 40.2 +/- 9.5 26.8-58.2 
































































































Cause and manner of death 
 
1 Morphine ICB 100 ICB/SB = 1.15 
ICB/FB = 1.25 





  SB 86 SB/FB = 1.08 
SB/PB = 0.93 
  
  FB 79 FB/PB = 0.85   
  PB 93    
2 Diazepam ICB 282 ICB/SB = 0.67 
ICB/FB = 0.72 





  SB 422 SB/FB = 1.05 
SB/PB = 1.64 
  
  FB 390 FB/PB = 1.51   
  PB 257    
 
Methadone ICB 1020 ICB/SB = 0.70 
ICB/FB = 0.77 
ICB/PB = 1.43 
Oral  
  SB 1455 SB/FB = 1.10 
SB/PB = 2.04 
  
  FB 1325 FB/PB = 1.85   
  PB 714    
 Morphine ICB 31 ICB/SB = 0.97 
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ICB/PB = 1.63 
  SB 32 SB/FB = 1.03 
SB/PB = 1.68 
  
  FB 31 FB/PB = 1.63   
  PB 19    
3 Diazepam ICB 339 ICB/SB = 1.05 
ICB/FB = 0.89 





  SB 323 SB/FB = 0.85 
SB/PB = 1.23 
  
  FB 378 FB/PB = 1.44   
  PB 262    
 
Methadone ICB 375 ICB/SB = 1.12 
ICB/FB = 2.37 
ICB/PB = 2.95 
Oral  
  SB 334 SB/FB = 2.11 
SB/PB = 2.63 
  
  FB 158 FB/PB = 1.24   
  PB 127    
4 Diazepam ICB 1299 ICB/SB = 1.08 
ICB/FB = 1.46 





  SB 1201 SB/FB = 1.35 
SB/PB = 1.46 
  
  FB 888 FB/PB = 1.08   
  PB 823    
 
Methadone ICB 1754 ICB/SB = 0.96 
ICB/FB = 1.20 
ICB/PB = 1.68 
Oral  
  SB 1825 SB/FB = 1.25 
SB/PB = 1.75 
  
  FB 1462 FB/PB = 1.40   
  PB 1041    
 Morphine ICB 10 ICB/SB = 0.50 
ICB/FB = 0.66 
ICB/PB = 1.11 
Smoke  
  SB 20 SB/FB = 1.33 
SB/PB = 2.22 
  
  FB 15 FB/PB = 1.66   
  PB 9    
5 Methadone ICB 338 ICB/SB = 1.66 
ICB/FB = 1.51 





  SB 203 SB/FB = 0.91 
SB/PB = 1.12 
  
  FB 223 FB/PB = 1.24   
  PB 180    
6 Morphine ICB 80 ICB/SB = 1.53 
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ICB/PB = 2.35 
  SB 52 SB/FB = 1.37 
SB/PB = 1.53 
  
  FB 38 FB/PB = 1.12   
  PB 34    
7 Diazepam ICB 232 ICB/SB = 0.71 
ICB/FB = 0.91 





  SB 328 SB/FB = 1.29 
SB/PB = 1.32 
  
  FB 255 FB/PB = 1.02   
  PB 249    
 
Methadone ICB 685 ICB/SB = 1.06 
ICB/FB = 2.23 
ICB/PB = 2.44 
Oral  
  SB 647 SB/FB = 2.11 
SB/PB = 2.30 
  
  FB 307 FB/PB = 1.09   
  PB 281    
8 Morphine ICB 38 ICB/SB = 1.53 
ICB/FB = 2.10 





  SB 67 SB/FB = 1.37 
SB/PB = 1.53 
  
  FB 58 FB/PB = 1.12   
  PB 46    
9 Diazepam ICB 149 ICB/SB = 1.01 
ICB/FB = 1.27 





  SB 147 SB/FB = 1.26 
SB/PB = 1.21 
  
  FB 117 FB/PB = 0.97   
  PB 121    
 
Methadone ICB 424 ICB/SB = 1.64 
ICB/FB = 3.75 
ICB/PB = 4.12 
Oral  
  SB 259 SB/FB = 2.29 
SB/PB = 2.51 
  
  FB 113 FB/PB = 1.10   
  PB 103    
 Morphine ICB 252 ICB/SB = 0.73 
ICB/FB = 1.27 
ICB/PB = 1.79 
Injection  
  SB 346 SB/FB = 1.75 
SB/PB = 2.45 
  
  FB 198 FB/PB = 1.40   
  PB 141    
10 Methadone ICB 536 ICB/SB = 0.52 
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ICB/PB = 0.81 
  SB 1026 SB/FB = 1.37 
SB/PB = 1.55 
  
  FB 749 FB/PB = 1.13   
  PB 663    
11 Methadone ICB 1216 ICB/SB = 1.31 
ICB/FB = 1.12 





  SB 926 SB/FB = 0.86 
SB/PB = 1.20 
  
  FB 1080 FB/PB = 1.40   
  PB 772    
12 Diazepam ICB 936 ICB/SB = 1.03 
ICB/FB = 0.92 





  SB 909 SB/FB = 0.89 
SB/PB = 0.99 
  
  FB 1019 FB/PB = 1.10   
  PB 921    
 
Methadone ICB 635 ICB/SB = 0.83 
ICB/FB = 0.84 
ICB/PB = 1.20 
Oral  
  SB 761 SB/FB = 1.00 
SB/PB = 1.44 
  
  FB 759 FB/PB = 1.43   
  PB 528    
 Morphine ICB 31 ICB/SB = 1.00 
ICB/FB = 1.15 
ICB/PB = 1.29 
Smoke  
  SB 31 SB/FB = 1.15 
SB/PB = 1.29 
  
  FB 27 FB/PB = 1.29   
  PB 24    
13 Diazepam ICB 1539 ICB/SB = 1.29 
ICB/FB = 1.04 





  SB 1194 SB/FB = 0.81 
SB/PB = 1.20 
  
  FB 1475 FB/PB = 1.49   
  PB 990    
 
Methadone ICB 868 ICB/SB = 1.92 
ICB/FB = 2.12 
ICB/PB = 2.81 
Oral  
  SB 453 SB/FB = 1.11 
SB/PB = 1.46 
  
  FB 409 FB/PB = 1.32   
  PB 309    
 Morphine ICB 19 ICB/SB = 1.35 
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ICB/PB = 1.46 
  SB 14 SB/FB = 0.87 
SB/PB = 1.08 
  
  FB 16 FB/PB = 1.23   
  PB 13    
14 Methadone ICB 182 ICB/SB = 0.71 
ICB/FB = 0.91 





  SB 449 SB/FB = 1.29 
SB/PB = 1.32 
  
  FB 310 FB/PB = 1.02   
  PB 195    
 
Morphine ICB 11 ICB/SB = 1.06 
ICB/FB = 2.23 
ICB/PB = 2.44 
Smoke  
  SB 20 SB/FB = 2.11 
SB/PB = 2.30 
  
  FB 15 FB/PB = 1.09   
  PB 9    
15 Methadone ICB 138 ICB/SB = 1.02 
ICB/FB = 1.79 





  SB 135 SB/FB = 1.75 
SB/PB = 1.92 
  
  FB 77 FB/PB = 1.10   
  PB 70    
16 Diazepam ICB 61 ICB/SB = 0.83 
ICB/FB = 0.73 





  SB 73 SB/FB = 0.88 
SB/PB = 0.88 
  
  FB 83 FB/PB = 1.00   
  PB 83    
 
Methadone ICB 822 ICB/SB = 2.38 
ICB/FB = 2.73 
ICB/PB = 3.22 
Oral  
  SB 345 SB/FB = 1.15 
SB/PB = 1.35 
  
  FB 301 FB/PB = 1.18   
  PB 255    
17 Methadone ICB 92 ICB/SB = 0.76 
ICB/FB = 0.66 
ICB/PB = 1.13 
Oral 
 
Methadone and Heroin Intoxication 
Accident 
  SB 121 SB/FB = 0.88 
SB/PB = 1.49 
  
  FB 138 FB/PB = 1.70   
  PB 81    
 
Morphine ICB 61 ICB/SB = 1.03 
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ICB/PB = 1.45 
  SB 59 SB/FB = 1.09 
SB/PB = 1.40 
  
  FB 54 FB/PB = 1.28   
  PB 42    
18 Methadone ICB 527 ICB/SB = 0.60 
ICB/FB = 0.93 





  SB 881 SB/FB = 1.55 
SB/PB = 1.71 
  
  FB 566 FB/PB = 1.10   
  PB 515    
 
Morphine ICB 8 ICB/SB = 1.23 
ICB/FB = 1.60 
ICB/PB = 2.28 
Smoke  
  SB 6.5 SB/FB = 1.30 
SB/PB = 1.86 
  
  FB 5 FB/PB = 1.43   
  PB 3.5    
19 Diazepam ICB 97 ICB/SB = 0.45 
ICB/FB = 0.21 





  SB 217 SB/FB = 0.46 
SB/PB = 2.01 
  
  FB 467 FB/PB = 4.34   
  PB 107    
 
Methadone ICB 204 ICB/SB = 0.44 
ICB/FB = 0.62 
ICB/PB = 0.84 
Oral  
  SB 466 SB/FB = 1.42 
SB/PB = 1.91 
  
  FB 328 FB/PB = 1.34   
  PB 244    
20 Morphine ICB 481 ICB/SB = 1.33 
ICB/FB = 2.32 





  SB 359 SB/FB = 1.73 
SB/PB = 1.61 
  
  FB 207 FB/PB = 0.92   
  PB 223    
21 Diazepam ICB 187 ICB/SB = 0.60 
ICB/FB = 0.40 





  SB 309 SB/FB = 0.67 
SB/PB = 1.74 
  
  FB 463 FB/PB = 2.61   
  PB 177    
 
Morphine ICB 43 ICB/SB = 2.61 
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ICB/PB = 5.37 
  SB 16 SB/FB = 2.00 
SB/PB = 2.00 
  
  FB 8 FB/PB = 1.00   
  PB 8    
22 Diazepam ICB 9 ICB/SB = 0.50 
ICB/FB = 0.47 
ICB/PB = 0.62 
Oral 
 
Methadone and Cocaine Intoxication 
Accident 
  SB 18 SB/FB = 0.95 
SB/PB = 1.24 
  
  FB 19 FB/PB = 1.31   
  PB 14    
 
Methadone ICB 422 ICB/SB = 0.81 
ICB/FB = 0.74 
ICB/PB = 0.86 
Oral  
  SB 519 SB/FB = 0.91 
SB/PB = 1.06 
  
  FB 571 FB/PB = 1.16   
  PB 490    
 Morphine ICB 10 ICB/SB = 1.00 
ICB/FB = 1.00 
ICB/PB = 1.18 
Smoke  
  SB 10 SB/FB = 1.00 
SB/PB = 1.18 
  
  FB 10 FB/PB = 1.18   
  PB 8.5    
23 Methadone ICB 848 ICB/SB = 0.63 
ICB/FB = 0.99 
ICB/PB = 0.87 
Oral 
 
Methadone and Heroin I toxication 
Suicide 
  SB 1356 SB/FB = 1.59 
SB/PB = 1.39 
  
  FB 852 FB/PB = 0.88   
  PB 969    
 
Morphine ICB 143 ICB/SB = 0.94 
ICB/FB = 1.36 
ICB/PB = 1.54 
Smoke  
  SB 152 SB/FB = 1.45 
SB/PB = 1.64 
  
  FB 105 FB/PB = 1.13   
  PB 92    
24 Methadone ICB 703 ICB/SB = 0.81 
ICB/FB = 1.11 





Accident vs Natural 
  SB 870 SB/FB = 1.37 
SB/PB = 2.02 
  
  FB 633 FB/PB = 1.47   
  PB 431    
25 Diazepam ICB 130 ICB/SB = 1.37 
ICB/FB = 1.16 
Oral 
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ICB/PB = 1.15 
  SB 95 SB/FB = 0.85 
SB/PB = 0.84 
  
  FB 111 FB/PB = 0.99   
  PB 113    
 
Methadone ICB 808 ICB/SB = 1.09 
ICB/FB = 5.98 
ICB/PB = 6.23 
Oral  
  SB 740 SB/FB = 5.48 
SB/PB = 5.72 
  
  FB 135 FB/PB = 1.04   
  PB 129    
26 Diazepam ICB 1345 ICB/SB = 1.41 
ICB/FB = 1.06 





  SB 956 SB/FB = 0.75 
SB/PB = 1.03 
  
  FB 1267 FB/PB = 1.37   
  PB 925    
 
Methadone ICB 32473 ICB/SB = 2.27 
ICB/FB = 2.96 
ICB/PB = 4.04 
Oral  
  SB 14302 SB/FB = 1.30 
SB/PB = 1.79 
  
  FB 10944 FB/PB = 1.36   
  PB 8040    
 Morphine ICB 124 ICB/SB = 2.69 
ICB/FB = 3.54 
ICB/PB = 4.51 
Smoke  
  SB 46 SB/FB = 1.31 
SB/PB = 1.67 
  
  FB 35 FB/PB = 1.27   
  PB 27    
27 Diazepam ICB 362 ICB/SB = 0.73 
ICB/FB = 0.96 
ICB/PB = 0.98 
Oral 
 
Polymedication and Heroin I toxication 
Accident 
  SB 495 SB/FB = 1.31 
SB/PB = 1.33 
  
  FB 377 FB/PB = 1.01   
  PB 370    
 
Morphine ICB 164 ICB/SB = 0.88 
ICB/FB = 1.72 
ICB/PB = 2.20 
Smoke  
  SB 185 SB/FB = 1.95 
SB/PB = 2.49 
  
  FB 95 FB/PB = 1.27   
  PB 74    
28 Methadone ICB 185 ICB/SB = 0.54 
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ICB/PB = 1.06 
  SB 340 SB/FB = 1.57 
SB/PB = 1.95 
  
  FB 216 FB/PB = 1.24   
  PB 174    
29 Diazepam ICB 13 ICB/SB = 0.48 
ICB/FB = 0.39 





  SB 27 SB/FB = 0.81 
SB/PB = 0.96 
  
  FB 33 FB/PB = 1.18   
  PB 28    
 
Methadone ICB 134 ICB/SB = 0.42 
ICB/FB = 0.49 
ICB/PB = 0.51 
Oral  
  SB 322 SB/FB = 1.17 
SB/PB = 1.23 
  
  FB 275 FB/PB = 1.05   
  PB 261    
30 Methadone ICB 276 ICB/SB = 0.28 
ICB/FB = 0.60 





  SB 978 SB/FB = 2.13 
SB/PB = 2.35 
  
  FB 459 FB/PB = 1.10   










TABLE 4—Mean concentrations ratios according to targeted substances. 
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Diazepam ICB/SB 14 0.87 +/-0.33 0.45 0.79 1.41 0.22 
 ICB/FB 14 0.81 +/-0.35 0.21 0.90 1.46 0.058 
 ICB/PB 14 1.06 +/-0.33 0.46 1.04 1.58 0.54 
 SB/FB 14 0.93 +/-0.25 0.46 0.86 1.35 0.33 
 SB/PB 14 1.28 +/-0.34 0.84 1.24 2.02 0.011 
 FB/PB 14 1.53 +/-0.91 0.97 1.24 4.35 0.005* 
Methadone ICB/SB 24 1.01 +/-0.58 0.28 0.82 2.38 0.62 
 ICB/FB 24 1.57 +/-1.29 0.49 1.05 5.99 0.22 
 ICB/PB 24 1.91 +/-1.38 0.51 1.50 6.24 0.0022* 
 SB/FB 24 1.58 +/-0.93 0.86 1.37 5.49 <0.0001* 
 SB/PB 24 1.93 +/-0.92 1.06 1.77 5.72 <0.0001* 
 FB/PB 24 1.27 +/-0.23 0.88 1.24 1.85 <0.0001* 
Morphine ICB/SB 17 1.22 +/-0.62 0.50 0.91 2.70 0.35 
 ICB/FB 17 1.73 +/-1.27 0.66 1.26 5.73 0.015 
 ICB/PB 17 2.05 +/-1.25 0.83 1.55 5.38 0.0001* 
 SB/FB 17 1.36 +/-0.36 0.85 1.31 2.20 0.0003* 
 SB/PB 17 1.69 +/-0.45 0.93 1.65 2.49 <0.0001* 
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Substance Ratios N Mean PMI (h) +/-
SD 
Correlation Spearman p-value 
Diazepam ICB/SB 14 31.30 +/-20.93 0.15 0.60 
 ICB/FB 14  -0.0015 0.96 
 ICB/PB 14  0.42 0.14 
 SB/FB 14  -0.40 0.16 
 SB/PB 14  0.33 0.25 
 FB/PB 14  0.57 0.032* 
Methadone ICB/SB 24 31.13 +/-15.23 -0.18 0.39 
 ICB/FB 24  -0.21 0.33 
 ICB/PB 24  -0.10 0.64 
 SB/FB 24  -0.023 0.92 
 SB/PB 24  0.29 0.18 
 FB/PB 24  0.55 0.0057* 
Morphine ICB/SB 17 35.04 +/-18.42 0.32 0.21 
 ICB/FB 17  0.16 0.55 
 ICB/PB 17  0.051 0.84 
 SB/FB 17  0.069 0.79 
 SB/PB 17  -0.21 0.42 
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Figure Legends 
 
FIG. 1a—Diazepam concentrations distribution.   
 
FIG. 1b—Methadone concentrations distribution. 
 
FIG. 1c—Morphine concentrations distribution. 
 
FIG. 2—Diazepam, methadone and morphine mean co centrations difference.s 
 
FIG. 3—Diazepam, methadone and morphine mean ratios.  
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
jfo_13061_f1a.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
jfo_13061_f1b.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
jfo_13061_f1c.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
jfo_13061_f2.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
jfo_13061_f3.tif
This	article	is	protected	by	copyright.	All	rights	reserved
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
